Tue, April 9, 2024
Mon, April 8, 2024
Fri, April 5, 2024
Thu, April 4, 2024
Wed, April 3, 2024

Aydin Huseynov Maintained (ACRV) at Strong Buy with Decreased Target to $14 on, Apr 5th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-14-on-apr-5th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Aydin Huseynov of Ladenburg Thalmann, Maintained "Acrivon Therapeutics, Inc." (ACRV) at Strong Buy with Decreased Target from $18 to $14 on, Apr 5th, 2024.

Aydin has made no other calls on ACRV in the last 4 months.



There are 3 other peers that have a rating on ACRV. Out of the 3 peers that are also analyzing ACRV, 0 agree with Aydin's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Aydin


  • Etzer Darout of "BMO Capital" Reiterated at Buy and Held Target at $18 on, Monday, April 1st, 2024
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $14 on, Monday, April 1st, 2024
  • Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024

Publication Contributing Sources